CurrentCignaPolicy IP0035

Prenatal Vitamins

Cigna coverage policy for prenatal vitamin supplements (including prescription-brand and generic prenatal vitamins) detailing prior authorization requirements, approval criteria for Employer Plans and Individual & Family Plans, and conditions considered not medically necessary.

Policy Summary

PayerCigna

PolicyPrenatal Vitamins

Policy CodePolicy IP0035

Change TypeCriteria revisedkeywords added

Effective DateMay 1, 2026

Next Review Date

Key ActionPrior Authorization is required; document trial of one generic prenatal vitamin or provide prescriber-documented significant clinical concern to receive a 1-year approval.

SourceLink

POLICY UPDATE CHANGES

Revised approval criteria to require trial of ONE generic prenatal vitamin formulation or prescriber-documented inability to use generics; receipt of samples does not satisfy trial.

Added Individual and Family Plan to the coverage table.

Added Gestyra tablets to policy keywords.

Annual revision noted 'No criteria changes' on 5/1/2026 after keyword updates.

1Required generic trial (number of formulations)

1 yearApproval duration when criteria met

12+Example products referenced

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Summary

Coverage stance: covered_with_criteria. Scope: Cigna coverage policy for prenatal vitamin supplements (including prescription-brand and generic prenatal vitamins) detailing prior authorization requirements, approval criteria for Employer Plans and Individual & Family Plans, and conditions considered not medically necessary. Subject: Prenatal Vitamins (Prenatal Vitamin Supplements). Approval duration when criteria met: 1 year. Effective date: 2026-05-01. Last review: 2026-05-01.

Key facts

Effective Date2026-05-01

Last Review2026-05-01

Policy NumberIP0035

Coverage StanceCovered with criteria (prior authorization required)

Approval Duration1 year when criteria met

Required generic trialTrial of 1 generic prenatal formulation required (receipt of samples does not satisfy)

Prior Authorization / Approval Criteria

Prior Authorization / Approval Criteria for Employer Plans and Individual and Family Plans

Approve for 1 year if the patient meets ONE of the following: Receipt of sample product does not satisfy this requirement. Prescriber attestation required in prior authorization documentation.

ONE of

Patient has tried ONE generic prenatal vitamin formulation (for example, Prenatal Plus, Prenatal Vitamin + Low Iron, Prenatal-19, Vitafol).
Receipt of sample product does not satisfy this requirement.
According to the prescriber, there is a significant clinical concern such that the patient is unable to use generic prenatal vitamins.
Prescriber attestation required in prior authorization documentation.

Prior Authorization

General Policy Statement & Not Covered Conditions

General Policy Statement

Prior Authorization is required for benefit coverage of Prenatal Vitamins.

All approvals are provided for the duration noted (approved duration: 1 year when criteria met).

Conditions Not Covered

Prenatal Vitamins are considered not medically necessary (when criteria are not met).

Policy states criteria will be updated as new published data are available.

Applicable Products / Examples

Examples of specific branded and generic prenatal products referencedmixed

AZeschew	Example product name listed in policy
Azesco	Example product name listed in policy
DermacinRx Prenatrix	Example product name listed in policy
DermacinRx	Example product name listed in policy
Gestyra	Example product name listed in policy; Gestyra tablets added in 5/1/2026 revision
Natal PNV	Example product name listed in policy
PNV Tab	Example product name listed in policy
Pregen DHA	Example product name listed in policy
Pregenna	Example product name listed in policy
Prental Vitamin Preparations (generic for NEO-VITAL RX)	Example product name listed in policy

1–10 of 17

1/2

Clinical Evidence and Guidelines

Evidence: USPSTF recommendation: USPSTF recommends daily 0.4-0.8 mg folic acid for women planning or capable of pregnancy (A recommendation). Background alignment: Policy aligns with ACA preventive service coverage requirements and USPSTF recommendation that women planning or capable of pregnancy take daily folic acid (0.4-0.8 mg).

Background

Background: Policy aligns with ACA preventive service coverage requirements and USPSTF recommendation that women planning or capable of pregnancy take daily folic acid (0.4-0.8 mg). Reasonable medical management techniques (for example, precertification, concurrent review, claim review) may be used to determine coverage limitations. Definition: Sample product — Manufacturer-provided sample; does not satisfy the requirement to have tried a generic prenatal vitamin formulation.

Revision History

5/1/2026addedLatest

Added Gestyra tablets to policy keywords (selected keyword update during annual revision).

5/1/2025revised

Revised approval criteria: changed requirement from documentation of inadequate response/contraindication/intolerance to FIVE covered prescription prenatal vitamins to approval for 1 year if patient has tried ONE generic prenatal vitamin formulation (e.g., Prenatal Plus, Prenatal Vitamin + Low Iron, Prenatal-19, Vitafol) or the prescriber documents a significant clinical concern preventing use of generics; receipt of sample product does not satisfy the trial requirement.